TFF Pharmaceuticals Comments on Animal Studies in the Development of High Potency Remdesivir as a Dry Powder for Inhalation by Thin Film Freezing

~ Scientists at the University of Texas at Austin report new pharmacokinetics data from the use of Thin Film Freezing technology to deliver remdesivir through dry powder inhalation ~ Dry powder formulation of remdesivir with leucine found to allow more sustained release of remdesivir from lung to plasma

Thank you for visiting Tailwinds Research. We are pleased to offer free research on select small and micro cap companies. It is free to join and we hope you’ll take the time to do so.

To create an account please click on this link.

If you already have an account, please log in here.

LEAVE A REPLY

Please enter your comment!
Please enter your name here